TDRL-505

N/A

Report date: 2023/03/02 16:29:50
NME

Base Information

Drug NameTDRL-505
Drug Alias NameTDRL-505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReplication Protein A inhibitors
TargetsReplication Protein A
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndiana University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesIndiana University School Of Medicine
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A